- Home
- GNE vs VSTM Comparison
GNE vs VSTM Comparison
Compare GNE & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GNE | VSTM |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.1M | 395.4M |
| IPO Year | 2011 | 2011 |
Fundamental Metrics
Financial Performance| Metric | GNE | VSTM |
|---|---|---|
| Price | $13.99 | $5.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $16.00 | ★ $16.50 |
| AVG Volume (30 Days) | 70.3K | ★ 2.4M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | ★ 95.65 | 17.49 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $425,202,000.00 | $30,914,000.00 |
| Revenue This Year | $17.49 | $282.64 |
| Revenue Next Year | $7.07 | $72.25 |
| P/E Ratio | $126.64 | ★ N/A |
| Revenue Growth | N/A | ★ 209.14 |
| 52 Week Low | $12.69 | $3.43 |
| 52 Week High | $18.92 | $11.25 |
Technical Indicators
Market Signals| Indicator | GNE | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 46.81 | 57.26 |
| Support Level | $13.44 | $5.53 |
| Resistance Level | $14.76 | $6.37 |
| Average True Range (ATR) | 0.35 | 0.40 |
| MACD | -0.04 | -0.08 |
| Stochastic Oscillator | 20.62 | 31.38 |
Price Performance
Historical ComparisonAbout GNE Genie Energy Ltd. Class B Stock
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.